NCT05269082View on ClinicalTrials.gov

A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers and Adults

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

September 19, 2022

Study Completion Date

September 19, 2022

Conditions
Drug Hypersensitivity
Interventions
OTHER

No intervention

This is a non-interventional study.

Trial Locations (1)

28401

PPD, Wilmington

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY